Picture of Achiko in Liquidation AG logo

ACHI Achiko in Liquidation AG News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: Achiko Obtains CE Mark For AptameXTM Covid-19 Rapid Test

May 17 (Reuters) - ACHIKO AG  ACHIN.S :
    * OBTAINS CE MARK FOR APTAMEXTM COVID-19 RAPID TEST
    * COMPANY EXPECTS TO HAVE APTAMEX IN WIDESPREAD COMMERCIAL
AVAILABILITY IN Q3 2022
    * COMPANY EXPECTS TO HAVE APTAMEX IN WIDESPREAD COMMERCIAL
AVAILABILITY IN Q3 2022
    * REGISTERED APTAMEX AND HAS OBTAINED A CE MARK, ALLOWING
PRODUCT
TO BE SOLD IN 27 COUNTRIES IN EU

Source text for Eikon:  ID:nEQ8mcJGsa 
Further company coverage:  ACHIN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Achiko in Liquidation AG

See all news